ScreenerHero

RLYB Rallybio Corporation

NAS · US · Healthcare · Biotechnology · rallybio.com
16.93USD-0.88%Mkt Cap: 89.94M $P/E: 2.11

Rallybio Corporation, a clinical-stage biotechnology company, engages in the development and commercialization of life-transforming therapies for patients suffering from severe and rare diseases. Its lead product candida…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap89.94M USD
Enterprise Value-2.15M USD
Revenue (TTM)646.00K USD
Gross Profit-9.18M USD
Net Income (TTM)-8.98M USD
Revenue/Share0.11 USD
Last Price16.93 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees7
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)2.11
P/E (Forward)-3.16
PEG—
EV/EBITDA0.09
EV/Revenue-3.32
P/S140.46
P/B0.96
EPS (TTM)8.01
EPS (Forward)-5.40
52W Range
3.67095% of range17.57
52W High17.57 USD
52W Low3.670 USD
Profitability
Gross Margin0.00%
Oper. Margin-3935.45%
EBITDA Margin0.00%
Profit Margin-1046.39%
ROE-15.49%
ROA-14.42%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-29.81M USD
CapEx (TTM)—
FCF Margin-2212.13%
FCF Yield-15.89%
Net Debt-92.85M USD
Net Debt/EBITDA3.66
Balance Sheet
Debt/Equity0.00
Current Ratio27.27
Quick Ratio26.03
Book Value/Sh17.81 USD
Cash/Share17.48 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:8
Split DateFeb 6, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.5.31M
Float1.74M
Insiders24.11%
Institutions86.14%
Short Interest
Short Ratio5.2d
Short % Float1.26%
Short % Out.1.05%
Shares Short55.56K
Short (prev mo.)54.56K
Technical
SMA 5016.71 (+1.3%)
SMA 20011.91 (+42.1%)
Beta-0.71
S&P 52W Chg16.45%
Avg Vol (30d)9.63K
Avg Vol (10d)8.51K
Technical Indicators
RSI (14)51.5
MACD0.0965
MACD Signal0.1133
MACD Hist.-0.0168
BB Upper17.35 USD
BB Middle16.91 USD
BB Lower16.48 USD
BB Width5.18%
ATR (14)0.3965 USD
Vol Ratio (20d)0.88x